Researchers make mathematical crystal ball to gaze into future of prostate cancer treatment
Aurora, CO, August 4, 2017 - The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects...Read More
Comprehensive sequencing program shows promise of precision medicine for advanced cancer
ANN ARBOR, Michigan, August 2, 2017 — The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To...Read More
Prostate Cancer Foundation Announces 2017 Young Investigator Award Recipients
SANTA MONICA, CA, July 10, 2017 -- The Prostate Cancer Foundation (PCF) today announced its 2017 Young Investigator (YI) Awards, which support early career scientists who are focused on accelerating...Read More
Precision medicine study finds new treatment for untreatable subtype of advanced prostate cancer
A clinical trial reported on at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that advanced prostate cancer patients whose tumors have a certain combination of mutations...Read More
Combination of two new therapies may be highly effective in advanced prostate cancer
Early results from a clinical trial presented at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that combining an immunotherapy with a targeted therapy may be highly...Read More
Immunotherapy and Prostate Cancer
Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer Checkpoint Inhibitors Miracle Drugs for Some, But Not Yet...Read More
Immunotherapy: Who’s Who in the Immune System
Part I Part II Part III A Vaccine for Prostate Cancer Who's Who in the Immune System Immunotherapy and Prostate Cancer Making sense of some very complicated stuff only...Read More
New three-in-one blood test opens door to precision medicine for prostate cancer
Test picks out men for treatment, detects early signs of resistance and monitors cancer’s evolution over time Advance is part of strategic push to overcome cancer evolution and drug resistance...Read More
Immunotherapy: A Vaccine for Prostate Cancer
https://vimeo.com/731870460/f451d6b79c In this three part series, we examine the latest advances in immunotherapy, one of the most promising strategies in cutting edge cancer research, and it's affects on prostate...Read More
PCF study finds that adding a 22-gene test to standard prostate cancer risk groups improves accuracy of patient prognosis
A PCF study presented at the 2017 American Society of Clinical Oncology (ACSO) Annual Meeting found that using a 22-gene test along with standard prostate cancer risk group features vastly...Read More